These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17707558)

  • 21. International standardization of diphtheria toxoids.
    GREENBERG L
    Bull World Health Organ; 1953; 9(6):829-36. PubMed ID: 13141134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pilot study of the safety and immonogenicity of the diphtheria adsorbed toxoid "d"].
    Rymkiewicz D; Zakrzewska A
    Przegl Epidemiol; 1994; 48(3):293-5. PubMed ID: 7938634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calibration of replacement international standards of diphtheria and tetanus toxoids for use in flocculation test.
    Preneta-Blanc R; Rigsby P; Wilhelmsen ES; Tierney R; Brierley M; Sesardic D
    Biologicals; 2008 Sep; 36(5):315-26. PubMed ID: 18676158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardization and validation of Vero cell assay for potency estimation of diphtheria antitoxin serum.
    Kumar S; Kanwar S; Bansal V; Sehgal R
    Biologicals; 2009 Oct; 37(5):297-305. PubMed ID: 19540135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physico-chemical and antigenic properties of tetanus and diphtheria toxoids and steps towards improved stability.
    Johansen P; Merkle HP; Gander B
    Biochim Biophys Acta; 1998 Oct; 1425(2):425-36. PubMed ID: 9795259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines.
    Coombes L; Stickings P; Tierney R; Rigsby P; Sesardic D
    J Immunol Methods; 2009 Oct; 350(1-2):142-9. PubMed ID: 19761770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical analysis of purified diphtheria toxoids: is toxoided then purified the same as purified then toxoided?
    Frech C; Hilbert AK; Hartmann G; Mayer K; Sauer T; Bolgiano B
    Dev Biol (Basel); 2000; 103():205-15. PubMed ID: 11214238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replacing the in vivo toxin challenge test with an in vitro assay for assessment of potency for diphtheria toxoid containing vaccines.
    Ming M; Caterini J; Ettorre L; Tang M; Schreiber M; Salha D; Gisonni-Lex L
    Biologicals; 2020 Nov; 68():19-25. PubMed ID: 33067107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the composition of diphtheria toxoids. II. Immunochemical and sedimentation characteristics of the components isolated by gel-filtration from different production batches of toxoids.
    Fish N; Dalin M; Polikar A
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Jun; 139(5):424-31. PubMed ID: 4247033
    [No Abstract]   [Full Text] [Related]  

  • 30. Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: applicability as alternative method for the safety testing of tetanus toxoids during vaccine production.
    Behrensdorf-Nicol HA; Bonifas U; Hanschmann KM; Krämer B; Weißer K
    Vaccine; 2013 Dec; 31(52):6247-53. PubMed ID: 24156922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of gel filtration and ammonium sulphate precipitation in the purification of diphtheria toxin and toxoid.
    Møyner K; Christiansen G
    Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):17-23. PubMed ID: 6711307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relative immunizing efficiency of diphtheria toxoid preparations.
    GREENBERG L
    Bull World Health Organ; 1955; 12(5):751-60. PubMed ID: 14379009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased sensitivity to diphtheria toxin of Vero cells cultured in serum-free medium.
    Piersma SJ; van der Gun JW; Hendriksen CF; Thalen M
    Biologicals; 2005 Jun; 33(2):117-22. PubMed ID: 15905099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Holt's diphtheria toxoid; an investigation as to reproducibility of antigenic properties in successive batches.
    BOUSFIELD G; DUKE HL
    Med Off; 1948 Oct; 80(14):145. PubMed ID: 18885776
    [No Abstract]   [Full Text] [Related]  

  • 35. Towards eliminating the use of animals for regulatory required vaccine quality control.
    Hendriksen CF
    ALTEX; 2006; 23(3):187-90. PubMed ID: 17086348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of physicochemical and immunochemical assays to replace animal tests in the quality control of toxoid vaccines. The report and recommendations of ECVAM workshop 61.
    Metz B; Brunel F; Chamberlin C; van der Gun J; Halder M; Jiskoot W; Kersten G; van Opstal O; Petersen JW; Ravetkar SD; Redhead K; Schwanig M; Wilhelmsen ES; Vann WF; Hendriksen C
    Altern Lab Anim; 2007 Jun; 35(3):323-31. PubMed ID: 17650951
    [No Abstract]   [Full Text] [Related]  

  • 37. Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement.
    Hendriksen CF
    Expert Rev Vaccines; 2009 Mar; 8(3):313-22. PubMed ID: 19249973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potency assay of diphtheria antitoxin in Vero cell microcultures.
    Sánchez Gómez R; Gallardo y Ramos R; González-Pacheco M
    Rev Latinoam Microbiol; 1996; 38(2):97-110. PubMed ID: 8986109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Formaldehyde-Induced Modifications in Diphtheria Toxin.
    Metz B; Michiels T; Uittenbogaard J; Danial M; Tilstra W; Meiring HD; Hennink WE; Crommelin DJA; Kersten GFA; Jiskoot W
    J Pharm Sci; 2020 Jan; 109(1):543-557. PubMed ID: 31678246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avidity as a parameter for diphtheria vaccine efficacy.
    el-Kady EM
    Egypt J Immunol; 2004; 11(1):47-54. PubMed ID: 15724386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.